UBS Group »

Syndax Pharmaceuticals shares owned by UBS Group

Quarter-by-quarter ownership of Syndax Pharmaceuticals (SNDX) shares owned by UBS Group from 13F filings

Historical chart of UBS Group investment in Syndax Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Syndax Pharmaceuticals held by UBS Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Syndax Pharmaceuticals by UBS Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $6.3M 291k 21.61
2023-09-30 $2.3M 155k 14.52
2023-06-30 $2.4M 113k 20.93
2023-03-31 $2.3M 108k 21.12
2022-12-31 $4.4M 173k 25.45
2022-09-30 $6.8M 286k 23.65
2022-06-30 $6.1M 317k 19.24
2022-03-31 $3.7M 215k 17.38
2021-12-31 $3.1M 141k 21.98
2021-09-30 $1.3M 71k 19.00
2021-06-30 $312k 18k 17.00
2021-03-31 $1.4M 63k 22.37
2020-12-31 $262k 12k 22.47
2020-09-30 $15k 1.0k 15.00
2020-06-30 $451k 30k 15.00
2020-03-31 $174k 16k 10.96
2019-12-31 $277k 31k 9.00
2019-09-30 $163k 22k 7.47
2019-06-30 $54k 5.7k 9.50
2019-03-31 $11k 2.0k 5.50
2018-12-31 $47k 11k 4.50
2018-09-30 $25k 3.1k 7.85
2018-06-30 $14k 2.0k 7.00
2018-03-31 $49k 3.4k 14.59
2017-12-31 $18k 2.0k 9.00
2017-09-30 $27k 2.4k 11.50
2017-06-30 $8.0k 541 14.79
2017-03-31 $20k 1.5k 13.58
2016-12-31 $6.0k 808 7.43
2016-09-30 $136k 9.0k 15.12
2016-06-30 $9.0k 871 10.33